pharmaphorum| News & views on pharma and biotech’s evolving future

News

FDA grants three priority vouchers to psychedelics

The FDA dropped a surprise Friday announcement that three more National Priority Vouchers would be given to a trio of psychedelics companies.

R&D

Women in STEM: Balancing the field from the beginning

pharmaphorum spoke with three female experts from Thermo Fisher Scientific about women in STEM today and tomorrow.

R&D

GLP-1 pricing and supply: Examining the signals behind the n...

R&D

Map with medicines and pipette superimposed for global clinical trials concept

The devil’s in the details: Navigating complexity & nuance i...

Clinical trial expansion comes with complexity and increased risk, as each country has distinct regulatory requirements and contractual expectations.

R&D

Innovative direct delivery strategies to unlock oligonucleot...

Oligo therapies are emerging as promising therapeutics with the potential to address previously untreatable conditions.

Featured Content

R&D

Women in STEM: Balancing the field from the beginning

pharmaphorum spoke with three female experts from Thermo Fisher Scientific about women in STEM today and tomorrow.

R&D

GLP-1 pricing and supply: Examining the signals behind the n...

/themes/custom/pharmaphorum_theme/library/img/article-label-image/register.png

R&D

From obesity to outcomes abstract visual

Sponsored

The future of cardiometabolic trials: From obesity to outcom...

Gain practical insight into how leading experts are designing the next generation of cardiometabolic trials in an upcoming webinar from hVIVO

Patients

pharmaphorum podcast Episode 256, Dean Erhardt, D2 Solutions

Providing patient access to new therapies, with Dean Erhardt

Dean Erhardt, founder of D2 Solutions, discusses patient access today versus the state of patient access tomorrow.

R&D

LSX2026: Endogenous tissue restoration in vascular disease –...

Paulo Neves, CMO of Xeltis, discusses transformative implants that enable the natural creation of living and long-lasting vessels.

R&D

Sponsored

A data-driven guide to small molecule drug discovery and dev...

A new white paper from Excelra takes a closer look at how discovery teams actually experience the small molecule development journey.

Newsletters and Deep Dive
digital magazine

Latest News

News

FDA grants three priority vouchers to psychedelics

The FDA dropped a surprise Friday announcement that three more National Priority Vouchers would be given to a trio of psychedelics companies.

News

FDA declines to approve AbbVie's Botox follow-up

AbbVie's bid to bring a rapid and shorter-acting botulinum toxin product to the US market has been knocked back by the FDA.

News

FDA clears first genetic hearing loss gene therapy

Regeneron's Otarmeni is the first gene therapy for congenital hearing loss to be cleared by the FDA, and will be made available for free in the US.

News

Ray's upscaled Series B, and other biofinancings

This week's crop of private financings includes nine-figure rounds for Ray Therapeutics and Tortugas, with Serif and Alloy also in on the action.

Views & Analysis

R&D

Women in STEM: Balancing the field from the beginning

pharmaphorum spoke with three female experts from Thermo Fisher Scientific about women in STEM today and tomorrow.

R&D

The devil’s in the details: Navigating complexity & nuance i...

Clinical trial expansion comes with complexity and increased risk, as each country has distinct regulatory requirements and contractual expectations.

R&D

Innovative direct delivery strategies to unlock oligonucleot...

Oligo therapies are emerging as promising therapeutics with the potential to address previously untreatable conditions.

Market Access

weight loss injections and measuring tape

Fighting fake GLP-1s to protect patients & preserve trust

Counterfeit drug promotion is a patient safety, brand equity, and public trust issue.

Deep Dive

R&D

The GLP-1 Reckoning

R&D

Redesigning obesity trials for a chronic disease era

R&D

GLP-1s: Five years that changed metabolic medicine

R&D

The trust gap: GLP-1s and the new information economy of obe...

White Papers & Webinar

R&D

Sponsored

The future of cardiometabolic trials: From obesity to outcom...

Gain practical insight into how leading experts are designing the next generation of cardiometabolic trials in an upcoming webinar from hVIVO

R&D

Sponsored

A data-driven guide to small molecule drug discovery and dev...

A new white paper from Excelra takes a closer look at how discovery teams actually experience the small molecule development journey.

Sales & Marketing

Sponsored

What HCPs Say Pharma Gets Wrong About Survey Research

Most market researchers already know the standard rules: keep surveys concise, write clear questions, and reduce unnecessary respondent burden.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Sales & Marketing

Sponsored

Using AI-driven synthetic personas to take your insights fur...

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.

Podcasts & Video

Patients

Providing patient access to new therapies, with Dean Erhardt

Dean Erhardt, founder of D2 Solutions, discusses patient access today versus the state of patient access tomorrow.

R&D

LSX2026: Endogenous tissue restoration in vascular disease –...

Paulo Neves, CMO of Xeltis, discusses transformative implants that enable the natural creation of living and long-lasting vessels.

Sales & Marketing

Sponsored

Pushing through barriers to commercial launch success, with ...

In this sponsored pharmaphorum podcast, Amanjeet Singh Saluja, a Principal at Axtria, discusses the current state of affairs in launch success.

Patients

pharmaphorum podcast Episode 254, Thomas Goetz, Drug Story

Every drug is a story, with Thomas Goetz

Thomas Goetz, creator and host of the Drug Story podcast on recognising pharmaceutical medicine as the socially and morally complex market that it is.

Axtria Ignite 2026 returns June 10–11 in Princeton, New Jersey

Featured Content

Editor's Picks

Latest News

Views & Analysis

Deep Dive

White Papers & Webinar

Podcasts & Video

Partner Content